First Time Loading...

Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.485 AUD 3.19% Market Closed
Updated: May 8, 2024

Immutep Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immutep Ltd
Revenue Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Immutep Ltd
ASX:IMM
Revenue
AU$256.6k
CAGR 3-Years
-61%
CAGR 5-Years
-45%
CAGR 10-Years
-24%
Mesoblast Ltd
ASX:MSB
Revenue
$7.5m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Revenue
$14.2B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
10%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Revenue
AU$87.3m
CAGR 3-Years
31%
CAGR 5-Years
25%
CAGR 10-Years
42%
Telix Pharmaceuticals Ltd
ASX:TLX
Revenue
AU$502.5m
CAGR 3-Years
359%
CAGR 5-Years
381%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Revenue
AU$21.5m
CAGR 3-Years
99%
CAGR 5-Years
377%
CAGR 10-Years
32%

See Also

What is Immutep Ltd's Revenue?
Revenue
256.6k AUD

Based on the financial report for Dec 31, 2023, Immutep Ltd's Revenue amounts to 256.6k AUD.

What is Immutep Ltd's Revenue growth rate?
Revenue CAGR 10Y
-24%

Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for Immutep Ltd have been -61% over the past three years , -45% over the past five years , and -24% over the past ten years .